Log in or Sign up for Free to view tailored content for your specialty!
Gastroenterology News
Acamprosate, oral naltrexone linked to improved outcomes in alcohol use disorder
Acamprosate and oral naltrexone were associated with significantly improved alcohol consumption outcomes compared with placebo and could be used alongside psychosocial interventions as first-line treatment for alcohol use disorder.
Most US veterans with anemia, hematochezia do not undergo testing for early-onset CRC
Diagnostic test completion for early age-onset colorectal cancer is low among U.S. veterans presenting with iron-deficiency anemia or hematochezia, with women and Black and Hispanic veterans less likely to undergo follow-up testing.
Log in or Sign up for Free to view tailored content for your specialty!
Liquid biopsy not cost-effective as alternative to colonoscopy for CRC screening
The cost of liquid biopsy for second-line colorectal cancer screening was not cost-effective and would have to be reduced by 66% to increase uptake among the general population, according to data in JAMA Network Open.
‘Small difference’ in colorectal neoplasia recurrence at 5 vs. 10 years after polypectomy
Study findings support performing surveillance colonoscopy 7 to 10 years after detection and polypectomy of baseline non-advanced adenoma rather than at 5 years, researchers wrote in the Journal of Gastroenterology and Hepatology.
VIDEO: National commitment critical to HCV elimination efforts
BOSTON — In this video, John W. Ward, MD, discusses strategies to drive the elimination of hepatitis C virus, including commitment on a national scale.
VIDEO: ‘Rich’ toolbox of strategies can help advance HCV testing, treatment
BOSTON — In this video, John W. Ward, MD, discusses multiple presentations at The Liver Meeting that focused on testing and treatment for hepatitis C virus infection.
VIDEO: HCV elimination efforts must focus on health disparities
BOSTON — In this video, John W. Ward, MD, spoke with Healio about two presentations from The Liver Meeting that highlighted ways to overcome health disparities among patients with hepatitis C virus infection.
Oral androgen receptor agonist improves sarcopenia, encephalopathy in cirrhosis
BOSTON — LPCN 1148, an oral androgen receptor agonist, improved sarcopenia, hepatic encephalopathy and other biomarkers associated with end-stage liver disease among men with advanced cirrhosis and clinical decompensation.
VIDEO: Access to generic DAA treatment critical for HCV elimination
BOSTON — Treatment of hepatitis C virus infection in low- and middle-income countries is key to global elimination efforts, according to an abstract presented at The Liver Meeting.
VIDEO: Risk for cancer, other events remains after cure for HCV-related cirrhosis
BOSTON — Patients with hepatitis C virus-related cirrhosis who achieve sustained virologic response remain at risk for cancer, as well as other non-liver-related events such as diabetes, according to an abstract presented at The Liver Meeting.
-
Headline News
Severe carbohydrate restriction not necessary for ketosis, weight loss in low-energy diets
November 25, 20242 min read -
Headline News
Triple-digit heat exposure may increase odds of atrial fibrillation
November 16, 20242 min read -
Headline News
Vaccine using live-attenuated malaria parasites shows promise
November 25, 20242 min read
-
Headline News
Severe carbohydrate restriction not necessary for ketosis, weight loss in low-energy diets
November 25, 20242 min read -
Headline News
Triple-digit heat exposure may increase odds of atrial fibrillation
November 16, 20242 min read -
Headline News
Vaccine using live-attenuated malaria parasites shows promise
November 25, 20242 min read